[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100658189":3},{"organization":4,"outcomesModule":7,"designInfo":13,"detailedDescription":16,"studyPopulation":17,"armGroups":12,"interventions":12,"overallOfficials":18,"centralContacts":23,"locations":12,"responsibleParty":29,"collaborators":12,"id":31,"slug":32,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":36,"acronym":37,"eligibilityCriteria":38,"healthyVolunteers":33,"sex":39,"minAge":40,"maxAge":12,"enrollmentInfo":41,"targetDuration":12,"studyType":44,"phases":12,"briefSummary":16,"conditions":45,"keywords":48,"overallStatus":58,"whyStopped":12,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":64,"leadSponsor":66,"locationsCount":12},{"fullName":5,"class":6},"University Hospital, Strasbourg, France","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":12,"otherOutcomes":12},[9],{"measure":10,"description":10,"timeFrame":11},"Assessment of the frequency of TNF in patients with multiple sclerosis","Baseline",null,{"allocation":12,"interventionModel":12,"interventionModelDescription":12,"primaryPurpose":12,"observationalModel":14,"timePerspective":15,"maskingInfo":12},"CASE_ONLY","PROSPECTIVE","Multiple sclerosis (MS) and functional neurological disorders (FND) share clinical features, which may result in FND being overlooked in patients with MS. They also share common comorbidities, including depression and alexithymia.\n\nAs their management differs, assessing the frequency and determinants of FND in patients with MS is important to improve diagnosis and ensure appropriate management.","During a routine medical visit, eligible patients will be informed about the study and invited to participate.\n\nThe two participating centers, located in Strasbourg and Nancy, each have an active cohort allowing the required number of participants to be recruited within one year.",[19],{"name":20,"affiliation":21,"role":22},"BIGAUT Kevin, Doctor","Hôpitaux Universitaires de Strasbourg","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":12,"email":28},"BEN HADJ HAMED Monia","CONTACT","003388116711","monia.ben-hadj-hamed@chru-strasbourg.fr",{"type":30,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR","100658189","assessment-of-the-frequency-of-functional-neurological-disorders-in-multiple-sclerosis-and-analysis-of-clinical-and-psychological-determinants-a-multicenter-cross-sectional-study-100658189",false,"NCT07849816","Assessment of the Frequency of Functional Neurological Disorders in Multiple Sclerosis and Analysis of Clinical and Psychological Determinants","Assessment of the Frequency of Functional Neurological Disorders in Multiple Sclerosis and Analysis of Clinical and Psychological Determinants: A Multicenter Cross-Sectional Study","FTNF-SEP","Inclusion Criteria:\n\n* Adult patient (≥ 18 years of age)\n* Diagnosis of multiple sclerosis (MS) according to the 2024 McDonald criteria\n* Stable brain MRI performed within the previous 12 months\n* No relapse between the MRI and study enrollment\n* Ability to understand French\n* Affiliated with the French national health insurance system\n* Willing to participate in the study\n\nExclusion Criteria:\n\n* Patient unwilling to participate in the study\n* Known severe psychotic disorder\n* Patient under judicial protection (sauvegarde de justice)\n* Patient under guardianship or curatorship (tutelle or curatelle)","ALL","18 Years",{"count":42,"type":43},100,"ESTIMATED","OBSERVATIONAL",[46,47],"Functional Neurological Disorders","Multiple Sclerosis",[47,49,50,51,52,53,54,55,56,57],"Functional Neurological Symptoms Disorder","Neurological Disability","Disease Activity","Anxiety","Depression","Alexithymia","Quality of Life","Psychological Factors Comorbidities","Multiple sclerosis relapse","NOT_YET_RECRUITING","2026-10-02",{"date":61,"type":62},"2026-10-07","ACTUAL",{"date":59,"type":43},{"date":65,"type":43},"2027-10-01",{"name":5,"class":6}]